Celldex Therapeutics
CLDX
#4701
Rank
โ‚ฌ1.68 B
Marketcap
25,29ย โ‚ฌ
Share price
-0.51%
Change (1 day)
2.75%
Change (1 year)

Celldex Therapeutics (CLDX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.55 Billion

According to Celldex Therapeutics's latest financial reports the company's total assets are โ‚ฌ0.55 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.76 B80.77%
2023-12-31โ‚ฌ0.42 B28.09%
2022-12-31โ‚ฌ0.32 B-16.25%
2021-12-31โ‚ฌ0.39 B104.77%
2020-12-31โ‚ฌ0.19 B74.72%
2019-12-31โ‚ฌ0.10 B-19.43%
2018-12-31โ‚ฌ0.13 B-48.22%
2017-12-31โ‚ฌ0.26 B-27.82%
2016-12-31โ‚ฌ0.36 B18.04%
2015-12-31โ‚ฌ0.30 B51.4%
2014-12-31โ‚ฌ0.20 B-18.86%
2013-12-31โ‚ฌ0.25 B164.82%
2012-12-31โ‚ฌ94.9 M25.78%
2011-12-31โ‚ฌ75.45 M-8.71%
2010-12-31โ‚ฌ82.65 M-15.63%
2009-12-31โ‚ฌ97.97 M96.24%
2008-12-31โ‚ฌ49.92 M677.58%
2007-12-31โ‚ฌ6.42 M-86.22%
2006-12-31โ‚ฌ46.59 M51.42%
2005-12-31โ‚ฌ30.77 M-8.87%
2004-12-31โ‚ฌ33.76 M35.8%
2003-12-31โ‚ฌ24.86 M-26.23%
2002-12-31โ‚ฌ33.7 M-44.35%
2001-12-31โ‚ฌ60.56 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Seagen
SGEN
โ‚ฌ3.12 B 460.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.20 B-63.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ1.25 B 125.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ77.42 B 13,801.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ179.27 B 32,089.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ70.82 B 12,616.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
โ‚ฌ2.62 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA